Healthcare - Medical - Pharmaceuticals - NASDAQ - US
$ 0.0081
8 %
$ 5.57 M
Market Cap
None
P/E
INCOME STATEMENT
0
REVENUE
-13.5 M
OPERATING INCOME
-19.9 M
NET INCOME
EFFICIENCY
Earnings Waterfall
CannBioRx Life Sciences Corp.
| Revenue | 0 |
| Cost Of Revenue | 106 K |
| Gross Profit | -106 K |
| Operating Expenses | 13.4 M |
| Operating Income | -13.5 M |
| Other Expenses | 6.46 M |
| Net Income | -19.9 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | |
|---|---|---|---|---|---|---|---|
| REVENUE | |||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | |||||||
| Cost Of Revenue | 0.1 | 0.1 | 0.1 | 0.1 | 72.2 K | 0 | 0 |
| Gross Profit | (0.1) | (0.1) | (0.1) | (0.1) | 72.2 K | 0 | 0 |
| OPERATING INCOME | |||||||
| Operating Expenses | 13.4 | 39.6 | 20.2 | 9.8 | 25.2 | 14.5 | 0.3 |
| Selling, General and Administrative Expenses | 10.7 | 15.5 | 11.7 | 3.4 | 18.9 | 7.7 | 0.3 |
| Research and Development Expenses | 2.8 | 2.4 | 3.9 | 2.3 | 2.0 | 1.1 | 0 |
| Operating Income | (13.5) | (17.9) | (15.6) | (5.6) | (20.9) | (8.7) | (0.3) |
| PRE-TAX INCOME | |||||||
| Interest Income Expense | (44 828.0) | 26.7 K | 0.2 | 1.1 | 0.2 | 0 | 0 |
| Total Other Income | (8.8) | (21.8) | (4.7) | (5.3) | (4.5) | (5.8) | 0.7 |
| Pre-Tax Income | (22.3) | (39.7) | (20.3) | (10.9) | (25.4) | (14.5) | 0.3 |
| NET INCOME | |||||||
| Tax Provision | (2 349 414.0) | 0.9 | 23.2 K | 20.4 K | 9.5 K | 1 | 0.2 |
| Net Income | (19.9) | (38.7) | (20.3) | (12.0) | (25.4) | (14.5) | 0.1 |
| EPS | 52.6 | 387 | 248 | 255 | 876 | 1.45 K | 12.4 |